STRATA Skin Sciences, Inc. (SSKN)
USD 2.62
(-0.76%)
USD 2.62
(-0.76%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 24.78 Million USD | -6.19% |
| 2022 | 26.41 Million USD | 8.93% |
| 2021 | 24.25 Million USD | 33.18% |
| 2020 | 18.21 Million USD | -21.78% |
| 2019 | 23.28 Million USD | 13.7% |
| 2018 | 20.47 Million USD | 0.56% |
| 2017 | 20.36 Million USD | -10.38% |
| 2016 | 22.71 Million USD | 6.9% |
| 2015 | 21.25 Million USD | 68.63% |
| 2014 | 12.6 Million USD | -34.77% |
| 2013 | 19.31 Million USD | -7.84% |
| 2012 | 20.96 Million USD | 2.44% |
| 2011 | 20.46 Million USD | 1.12% |
| 2010 | 20.23 Million USD | 8.9% |
| 2009 | 18.58 Million USD | 1.68% |
| 2008 | 18.27 Million USD | 39.73% |
| 2007 | 13.07 Million USD | 8.08% |
| 2006 | 12.1 Million USD | 87.38% |
| 2005 | 6.45 Million USD | 106.6% |
| 2004 | 3.12 Million USD | 67.87% |
| 2003 | 1.86 Million USD | 103.5% |
| 2002 | 915 Thousand USD | -66.2% |
| 2001 | 2.7 Million USD | 51.48% |
| 2000 | 1.78 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 5.96 Million USD | 0.18% |
| 2024 Q2 | 5.42 Million USD | -9.15% |
| 2023 FY | 24.78 Million USD | -6.19% |
| 2023 Q1 | 6.97 Million USD | 3.87% |
| 2023 Q3 | 5.56 Million USD | -11.32% |
| 2023 Q4 | 5.95 Million USD | 6.99% |
| 2023 Q2 | 6.28 Million USD | -9.95% |
| 2022 Q1 | 6.43 Million USD | -65.07% |
| 2022 FY | 26.41 Million USD | 8.93% |
| 2022 Q4 | 6.71 Million USD | 1.96% |
| 2022 Q3 | 6.58 Million USD | -1.53% |
| 2022 Q2 | 6.68 Million USD | 3.98% |
| 2021 Q3 | 5.84 Million USD | 2.76% |
| 2021 Q2 | 5.68 Million USD | -6.9% |
| 2021 Q1 | 6.1 Million USD | 24.77% |
| 2021 FY | 24.25 Million USD | 33.18% |
| 2021 Q4 | 18.41 Million USD | 215.2% |
| 2020 Q2 | 3.57 Million USD | -33.07% |
| 2020 Q1 | 5.34 Million USD | -13.52% |
| 2020 Q3 | 4.39 Million USD | 22.69% |
| 2020 FY | 18.21 Million USD | -21.78% |
| 2020 Q4 | 4.89 Million USD | 11.43% |
| 2019 Q2 | 5.89 Million USD | 0.74% |
| 2019 Q4 | 6.18 Million USD | 15.48% |
| 2019 Q1 | 5.85 Million USD | 4.69% |
| 2019 Q3 | 5.35 Million USD | -9.15% |
| 2019 FY | 23.28 Million USD | 13.7% |
| 2018 Q4 | 5.58 Million USD | 14.16% |
| 2018 Q2 | 4.98 Million USD | -0.64% |
| 2018 Q1 | 5.01 Million USD | -2.47% |
| 2018 FY | 20.47 Million USD | 0.56% |
| 2018 Q3 | 4.89 Million USD | -1.71% |
| 2017 Q3 | 4.77 Million USD | -8.51% |
| 2017 Q2 | 5.22 Million USD | -0.11% |
| 2017 Q1 | 5.22 Million USD | 0.08% |
| 2017 FY | 20.36 Million USD | -10.38% |
| 2017 Q4 | 5.13 Million USD | 7.6% |
| 2016 Q1 | 6.33 Million USD | -15.54% |
| 2016 Q4 | 5.22 Million USD | 2.35% |
| 2016 Q3 | 5.1 Million USD | -15.78% |
| 2016 FY | 22.71 Million USD | 6.9% |
| 2016 Q2 | 6.05 Million USD | -4.39% |
| 2015 Q4 | 7.5 Million USD | -1.34% |
| 2015 Q1 | 3 Million USD | 6.25% |
| 2015 FY | 21.25 Million USD | 68.63% |
| 2015 Q3 | 7.6 Million USD | 142.01% |
| 2015 Q2 | 3.14 Million USD | 4.67% |
| 2014 Q4 | 2.82 Million USD | 6.24% |
| 2014 FY | 12.6 Million USD | -34.77% |
| 2014 Q3 | 2.65 Million USD | -17.06% |
| 2014 Q2 | 3.2 Million USD | -18.03% |
| 2014 Q1 | 3.91 Million USD | 7.58% |
| 2013 Q1 | 5.54 Million USD | 5.93% |
| 2013 FY | 19.31 Million USD | -7.84% |
| 2013 Q4 | 3.63 Million USD | -16.18% |
| 2013 Q3 | 4.33 Million USD | -25.16% |
| 2013 Q2 | 5.79 Million USD | 4.44% |
| 2012 Q1 | 5.65 Million USD | 24.59% |
| 2012 FY | 20.96 Million USD | 2.44% |
| 2012 Q4 | 5.23 Million USD | 7.61% |
| 2012 Q3 | 4.86 Million USD | -6.42% |
| 2012 Q2 | 5.2 Million USD | -7.97% |
| 2011 FY | 20.46 Million USD | 1.12% |
| 2011 Q1 | 4.96 Million USD | -11.36% |
| 2011 Q4 | 4.53 Million USD | -25.97% |
| 2011 Q3 | 6.12 Million USD | 26.91% |
| 2011 Q2 | 4.82 Million USD | -2.83% |
| 2010 Q4 | 5.6 Million USD | 12.8% |
| 2010 Q1 | 5.05 Million USD | -9.42% |
| 2010 FY | 20.23 Million USD | 8.9% |
| 2010 Q2 | 4.6 Million USD | -9.04% |
| 2010 Q3 | 4.96 Million USD | 8.02% |
| 2009 Q4 | 5.58 Million USD | 10.27% |
| 2009 Q2 | 3.87 Million USD | -4.65% |
| 2009 Q1 | 4.06 Million USD | -6.04% |
| 2009 FY | 18.58 Million USD | 1.68% |
| 2009 Q3 | 5.06 Million USD | 30.77% |
| 2008 Q4 | 4.32 Million USD | -1.05% |
| 2008 Q3 | 4.36 Million USD | -14.33% |
| 2008 Q2 | 5.09 Million USD | 13.69% |
| 2008 Q1 | 4.48 Million USD | 29.63% |
| 2008 FY | 18.27 Million USD | 39.73% |
| 2007 Q4 | 3.45 Million USD | 14.22% |
| 2007 Q2 | 3.32 Million USD | 1.85% |
| 2007 FY | 13.07 Million USD | 8.08% |
| 2007 Q3 | 3.02 Million USD | -8.9% |
| 2007 Q1 | 3.26 Million USD | -2.66% |
| 2006 Q1 | 3.06 Million USD | 20.45% |
| 2006 Q2 | 3.01 Million USD | -1.91% |
| 2006 Q3 | 2.57 Million USD | -14.4% |
| 2006 Q4 | 3.35 Million USD | 30.15% |
| 2006 FY | 12.1 Million USD | 87.38% |
| 2005 Q2 | 1.27 Million USD | 11.48% |
| 2005 Q4 | 2.54 Million USD | 86.22% |
| 2005 Q3 | 1.36 Million USD | 7.66% |
| 2005 FY | 6.45 Million USD | 106.6% |
| 2005 Q1 | 1.14 Million USD | -2.36% |
| 2004 Q3 | 626.07 Thousand USD | 0.0% |
| 2004 Q4 | 1.16 Million USD | 86.49% |
| 2004 FY | 3.12 Million USD | 67.87% |
| 2003 FY | 1.86 Million USD | 103.5% |
| 2002 FY | 915 Thousand USD | -66.2% |
| 2001 FY | 2.7 Million USD | 51.48% |
| 2000 FY | 1.78 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -120.786% |
| Cerus Corporation | 143.15 Million USD | 82.689% |
| OrthoPediatrics Corp. | 137.01 Million USD | 81.914% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -118.126% |
| Talis Biomedical Corporation | 67.18 Million USD | 63.116% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 0.661% |
| Inogen, Inc. | 236.08 Million USD | 89.503% |
| Spectral AI, Inc. | 20.86 Million USD | -18.774% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 55.746% |
| CVRx, Inc. | 76.14 Million USD | 67.454% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -602.41% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -98.423% |
| Orthofix Medical Inc. | 667.42 Million USD | 96.287% |
| Venus Concept Inc. | 80.47 Million USD | 69.207% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 56.2% |
| Bioventus Inc. | 409.91 Million USD | 93.955% |
| BrainsWay Ltd. | 28.01 Million USD | 11.553% |
| Envoy Medical, Inc. | 17.89 Million USD | -38.457% |
| electroCore, Inc. | 32.03 Million USD | 22.634% |
| IceCure Medical Ltd | 16.87 Million USD | -46.842% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 41.598% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -40.537% |
| MaxCyte, Inc. | 84.84 Million USD | 70.793% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -99.657% |
| Nexalin Technology, Inc. | 5.78 Million USD | -328.636% |
| PAVmed Inc | 64.82 Million USD | 61.774% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 51.484% |
| RxSight, Inc. | 103.85 Million USD | 76.138% |
| Sight Sciences, Inc. | 126.44 Million USD | 80.402% |
| SI-BONE, Inc. | 156.35 Million USD | 84.15% |
| TELA Bio, Inc. | 84.18 Million USD | 70.564% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 64.627% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 87.815% |
| LivaNova PLC | 843.54 Million USD | 97.062% |
| 908 Devices Inc. | 68.08 Million USD | 63.6% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 94.876% |
| Nemaura Medical Inc. | 7.13 Million USD | -247.131% |
| NeuroPace, Inc. | 75.29 Million USD | 67.089% |
| LENSAR, Inc. | 33.33 Million USD | 25.663% |
| Apyx Medical Corporation | 51.01 Million USD | 51.427% |
| Cutera, Inc. | 197.72 Million USD | 87.467% |
| BioSig Technologies, Inc. | 28.53 Million USD | 13.141% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 87.058% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 31.278% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 97.037% |
| Axonics, Inc. | 270.2 Million USD | 90.829% |
| Outset Medical, Inc. | 198.77 Million USD | 87.533% |
| IRIDEX Corporation | 31.81 Million USD | 22.107% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 86.25% |
| IRadimed Corporation | 30.12 Million USD | 17.733% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -190.448% |
| INVO Bioscience, Inc. | 7.85 Million USD | -215.549% |
| Telesis Bio, Inc. | 63.48 Million USD | 60.968% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 74.83% |
| Varex Imaging Corporation | 224.8 Million USD | 88.976% |
| Quipt Home Medical Corp. | 148.66 Million USD | 83.331% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -111.388% |
| Pulmonx Corporation | 112.68 Million USD | 78.009% |
| Dynatronics Corporation | 9.9 Million USD | -150.11% |
| Modular Medical, Inc. | 17.52 Million USD | -41.371% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -22.757% |
| Semler Scientific, Inc. | 38.94 Million USD | 36.368% |
| InMode Ltd. | 215.68 Million USD | 88.51% |
| Bruker Corporation | 1.07 Billion USD | 97.698% |
| Cytosorbents Corporation | 48.33 Million USD | 48.733% |
| DexCom, Inc. | 1.69 Billion USD | 98.535% |
| Align Technology, Inc. | 2.07 Billion USD | 98.807% |
| Viveve Medical, Inc. | 22.17 Million USD | -11.762% |
| ZimVie Inc. | 275.12 Million USD | 90.993% |
| Movano Inc. | 29.69 Million USD | 16.534% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 81.947% |
| Nexalin Technology, Inc. | 5.78 Million USD | -328.636% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -602.41% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 95.876% |
| Profound Medical Corp. | 33.6 Million USD | 26.254% |
| Insulet Corporation | 939.9 Million USD | 97.363% |
| enVVeno Medical Corporation | 25.23 Million USD | 1.811% |
| Surmodics, Inc. | 98.69 Million USD | 74.892% |
| iCAD, Inc. | 22.22 Million USD | -11.501% |
| Nuwellis, Inc. | 22.61 Million USD | -9.587% |
| Biotricity, Inc. | 17.18 Million USD | -44.205% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 94.442% |
| Aethlon Medical, Inc. | 12.27 Million USD | -101.841% |
| InspireMD, Inc. | 22.95 Million USD | -7.978% |
| PAVmed Inc. | 64.82 Million USD | 61.774% |
| BIOLASE, Inc. | 34.66 Million USD | 28.505% |
| Beyond Air, Inc. | 61.7 Million USD | 59.836% |
| FONAR Corporation | 28.6 Million USD | 13.367% |
| AxoGen, Inc. | 149.33 Million USD | 83.406% |
| Vivani Medical, Inc. | 26.96 Million USD | 8.099% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 86.007% |
| Inari Medical, Inc. | 448.59 Million USD | 94.476% |
| UFP Technologies, Inc. | 58.08 Million USD | 57.34% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -402.902% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -292.211% |
| Tenon Medical, Inc. | 16.96 Million USD | -46.045% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -235.195% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 43.811% |
| AdaptHealth Corp. | 1.07 Billion USD | 97.701% |
| Sintx Technologies, Inc. | 15.2 Million USD | -63.022% |
| NanoVibronix, Inc. | 4.97 Million USD | -398.311% |
| Quanterix Corporation | 118.1 Million USD | 79.017% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -111.388% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -71.59% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 93.689% |
| TransMedics Group, Inc. | 182.82 Million USD | 86.445% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 11.701% |
| NeuroMetrix, Inc. | 11.09 Million USD | -123.274% |
| Hyperfine, Inc. | 52.87 Million USD | 53.13% |
| Establishment Labs Holdings Inc. | 172 Million USD | 85.593% |
| Biomerica, Inc. | 6.97 Million USD | -255.13% |
| Bone Biologics Corporation | 9.42 Million USD | -162.836% |
| AVITA Medical, Inc. | 80.77 Million USD | 69.323% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -140.331% |
| Silk Road Medical, Inc | 186.35 Million USD | 86.702% |